Table 1.
Life Stage Group | Recommendations | Upper tolerable intake level | ||||
---|---|---|---|---|---|---|
D-A-CH1,2 | IOM3 | ES4,5 | EFSA6 | IOM | ES | |
Infants | ||||||
0–6 months | 400 | 400 | 400–1000 | 1000 | 1000 | 2000 |
6 to 12 months | 400 | 400 | 400–1000 | 1000 | 1500 | 2000 |
Children | ||||||
1–3 yr | 800 | 600 | 600–1000 | 2000 | 2500 | 4000 |
4–8 yr | 800 | 600 | 600–1000 | 2000 | 3000 | 4000 |
Males | ||||||
9–13 yr | 800 | 600 | 600–1000 | 2000–4000 | 4000 | 4000 |
14–18 yr | 800 | 600 | 600–1000 | 4000 | 4000 | 4000 |
19–30 yr | 800 | 600 | 1500–2000 | 4000 | 4000 | 10,000 |
31–50 yr | 800 | 600 | 1500–2000 | 4000 | 4000 | 10,000 |
51–70 yr | 800 | 600 | 1500–2000 | 4000 | 4000 | 10,000 |
70+ yr | 800 | 800 | 1500–2000 | 4000 | 4000 | 10,000 |
Females | ||||||
9.13 yr | 800 | 600 | 600–1000 | 4000 | 4000 | 4000 |
14–18 yr | 800 | 600 | 600–1000 | 4000 | 4000 | 4000 |
19–30 yr | 800 | 600 | 1500–2000 | 4000 | 4000 | 10,000 |
31–50 yr | 800 | 600 | 1500–2000 | 4000 | 4000 | 10,000 |
51–70 yr | 800 | 600 | 1500–2000 | 4000 | 4000 | 10,000 |
70+ yr | 800 | 800 | 1500–2000 | 4000 | 4000 | 10,000 |
Pregnancy | ||||||
14–18 yr | 800 | 600 | 600–1000 | 4000 | 4000 | 4000 |
19–30 yr | 800 | 600 | 1500–2000 | 4000 | 4000 | 10,000 |
31–50 yr | 800 | 600 | 1500–2000 | 4000 | 4000 | 10,000 |
Lactation | ||||||
14–18 yr | 800 | 600 | 600–1000 | 4000 | 4000 | 4000 |
19–30 yr | 800 | 600 | 1500–2000 | 4000 | 4000 | 10,000 |
31–50 yr | 800 | 600 | 1500–2000 | 4000 | 4000 | 10,000 |
1German, Austrian, Swiss Nutrition Societies. 2In the absence of skin synthesis of vitamin D. 3Institute of Medicine. 4Endocrine Society. 5For patients at risk for 25-hydroxyvitamin D levels < 50 nmol/L. 6European Food Safety Authority. Vitamin D data are presented as international units.